Co-Diagnostics, Inc. Accounts Receivable, after Allowance for Credit Loss, Noncurrent
Co-Diagnostics, Inc. (CODX) had Accounts Receivable, after Allowance for Credit Loss, Noncurrent of $75.00 thousand as of 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Accounts and Financing Receivable, after Allowance for Credit Loss, Noncurrent
us-gaap:AccountsReceivableNetNoncurrent · last filed 2022-05-12
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Noncurrent $75.00K.
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Noncurrent $75.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Noncurrent |
|---|---|
| 2022-03-31 | $75.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $75.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |